Jessica Lin and Zhenqi (Pete) Shi from Genentech describe a novel machine learning approach to predicting retention times for ...
The new Thermo Scientific µPAC Neo HPLC Column brings improved column-to-column reproducibility and better protein identification to proteomics researchers MINNEAPOLIS--(BUSINESS WIRE)--ASMS 2022 – ...
Agilent ZORBAX Rapid Resolution columns, with a 3.5 µm particle size, reduce analysis time and increase sample throughput for any application compared to 5 µm columns. Rapid Resolution columns are ...
HPLC is a widely used tool in peptide and protein purification. One of the challenges in this process is maximizing the lifetime of the bulk media sorbents or prepacked columns, which degrade due to ...
The Waters™ Alliance™ iS High Performance Liquid Chromatography (HPLC) System brings a new level of simplicity and instrument intelligence to QC analyses, helping laboratories eliminate up to 40% of ...
This detailed overview explains the technical mechanisms of LC-MS proteomics, including peptide separation, ion generation, ...
The ZORBAX RRHD 300-HILIC columns for glycopeptide analysis feature 1.8 µm particles and a 300Å pore size. These enable to resolve peptide glycoforms. The ZORBAX RRHD 300-HILIC columns are part of the ...
The first part of an end-of-the-year review of LCGC International’s editorial coverage of HPLC 2025, which took place in Bruges from 19–23 June 2025 .
In the past few years, high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) has matured to a true alternative to antibody-based immunoassays in routine therapeutic drug ...
Proteomics, clinical peptides and biopharmaceutical research laboratories performing high throughput, high-performance liquid chromatography (HPLC), or liquid chromatography-mass spectrometry (LC-MS) ...
The author describes how liquid chromatography-mass spectrometry works and explains some of its advantages and disadvantages, particularly compared to high-performance liquid chromatography. Within ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results